Iceland’s Controlant, with $50M backing, emerges as key player in Cold Chain for COVID-19 vaccine – NewsNifty

A startup hailing structure remote is arising as one of the central members in the competition to disseminate one of the key Coronavirus immunizations around the globe. Controlant — which has a remarkable constant inventory network checking innovation dependent on GSM networks and is explicitly outfitted to zones like drugs and life sciences — has affirmed it is giving its observing administrations to Pfizer as it conveys the mRNA-based Pfizer-BioNTech COVID-19 antibody around the world. The Controlant stage includes screen-based IoT labels which-connection to GSM organizations and afterward feed into web and portable apps.

Last week the Governor of New York a week ago held up a crate containing the immunization, with a unidentified label that resembled a Controlant GSM GPS beacon. TechCrunch reached Controllant and the organization affirmed that it was without a doubt their technology.

Controlant Cold Chain as a Service Solution

In September Controlant made sure about $15 million in Series B financing to drive the market development of its constant ‘Cold Chain as a Service’ stage. It has to a great extent Iceland-based speculators including Sjova and VIS. Frumtak, a VC firm in Iceland, first put resources into Controlant in 2011. The ongoing financing brought Controlant’s all out subsidizing to date to $50 million. Frumtak as of late sold 11% of its stake in Controlant (an exchange took care of by Arion Bank) for near $14 million, yet will keep on holding a 13% stake through its Frumtak II fund.

In expansion to the perceivability and observing arrangements that Controlant is giving to Pfizer, it’s likewise working straightforwardly with the U.S. Government, the CDC, U.S. Branch of Health and Human Services, and partners in ‘Activity Warp Speed’. The stage is being utilized all through the sum of the U.S. store network excursion of the vaccines.

Gisli Herjolfsson, Controlant CEO and Co-founder

Gisli Herjolfsson (imagined), prime supporter and CEO of Controlant, said in an explanation: “Controlant has amassed a profundity of aptitude in immunization store network activities and we are glad to have the occasion to apply our answers for the sum of the mRNA-based Pfizer-BioNTech COVID-19 antibody inventory network, through our immediate work with Pfizer and government stakeholders.”

Controlant IoT gadgets, stuffed with the antibodies, catch natural data, including time, temperature, and light occasions, and send the data, progressively, to Controlant’s exclusive platform.

Below is a video of Governor Andrew Cuomo demonstrating the common bundling which Controlant gadgets are connected to:

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Five VCs discuss what surprised them the most in 2020 – NewsNifty

Hello and welcome back to Equity, TechCrunch’s funding centered web recording (presently on…

Primer, the fintech helping merchants consolidate the payments stack, raises £14M Series A – NewsNifty

Primer, the U.K. fintech that needs to assist shippers with solidifying their…

Webflow raises $140M, pushing its valuation to $2.1 billion – NewsNifty

This morning Webflow, a product organization that assists organizations with building no-code…

The balkanization of the cloud is bad for everyone

China has since quite a while ago necessitated that cloud foundation be…

SpineZone is the latest health tech startup to raise millions in the musculoskeletal space – NewsNifty

SpineZone is a startup that makes customized practice projects and treatment for…

Apple scolds adtech, Facebook hit with antitrust suits, Twitter buys Squad – NewsNifty

Welcome back to This Week in Apps, the week after week TechCrunch arrangement that…

Fun photography gear to brighten up the holidays – NewsNifty

Welcome to TechCrunch’s 2020 Holiday Gift Guide! Need assistance with blessing thoughts?…

Pinterest says it will adopt workplace culture recommendations – NewsNifty

Pinterest has focused on embracing the suggestions from its exceptional advisory group…